Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients with Advanced Prostate Cancer: A Veterans Administration Cohort Study

To interrogate the National Veterans Health Administration (VA) database to determine if beta-blocker use at time of initiation of androgen therapy deprivation (ADT) would result in improved oncological outcomes in advanced prostate cancer.

Source: Urology - February 12, 2021 Category: Urology & Nephrology Authors: Natasza M. Posielski, Kyle A. Richards, Jinn-ing Liou, Tudor Borza, E. Jason Abel, Tracy M. Downs, David F. Jarrard Source Type: research